Keywords: ranbaxy, 3rd-qtr, net, profit, soars, third-quarter, profits
Ranbaxy's 3rd-qtr net profit soars 48%
Article | 05 November 2007
Third-quarter 2007 profits at New Dehli, India-based drugmaker Ranbaxy Laboratories jumped 48% to 2.07 billion rupees ($52.6 million), equivalent to earnings per share of 4.35 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
